Tin tức & Cập nhật
Lọc theo Chuyên ngành:
Jaundice, fluid retention in HCC tied to shorter survival
The presence of jaundice or fluid retention among patients with hepatocellular carcinoma (HCC) is associated with a shorter overall survival (OS), suggests a Singapore study.
Jaundice, fluid retention in HCC tied to shorter survival
21 Aug 2024
Multiple factors influence risks of cirrhosis, HCC in veterans with MAFLD
The incidence of cirrhosis and hepatocellular carcinoma (HCC) among veterans differs according to demographic and clinical characteristics, with the lowest rate seen among Asians, reports a study.
Multiple factors influence risks of cirrhosis, HCC in veterans with MAFLD
17 Aug 2024
Cabozantinib offers survival benefits to ICI-treated HCC patients
A phase II trial of cabozantinib demonstrates the study drug’s efficacy in patients with hepatocellular carcinoma (HCC) previously treated with immune checkpoint inhibitor (ICI) regimens.
Cabozantinib offers survival benefits to ICI-treated HCC patients
11 Aug 2024
CLD status does not influence MACE risk associated with ticagrelor vs clopidogrel
Use of ticagrelor compared with clopidogrel contributes to a similar risk of major adverse cardiovascular events (MACE) and a higher risk of major bleeding in acute coronary syndrome (ACS) patients undergoing percutaneous coronary intervention (PCI), reveals a study.
CLD status does not influence MACE risk associated with ticagrelor vs clopidogrel
01 Aug 2024
Sex, ethnic disparities affect evaluation, treatment rates of CHB patients
Evaluation and treatment rates of patients with chronic hepatitis B (CHB) remain poor worldwide and differ by sex and race or ethnicity, reports a real-world study.
